Nektar Therapeutics reports $741.7 million in cash and investments as of April 1

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Form 13D/A Sionna Therapeutics For: 20 April Hisse Senetleri 0 1
A Form DEF 14A Larimar Therapeutics For: 20 April Hisse Senetleri 0 1
A AnaptysBio completes spin-off of First Tracks Biotherapeutics Hisse Senetleri 0 1
A Ovid Therapeutics receives $53.9 million from warrant exercises Hisse Senetleri 0 1
A Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Hisse Senetleri 0 2
A Nektar presents rezpegaldesleukin data at dermatology meeting Hisse Senetleri 0 8
A Nektar presents rezpegaldesleukin data at dermatology meeting Hisse Senetleri 0 14
A Oppenheimer raises Nektar Therapeutics price target to $140 Hisse Senetleri 0 12

Benzer konular

Üst